| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | 0.32 | 8e-13 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.38 | 5e-10 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.39 | 1e-09 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | -0.26 | 2e-07 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | 0.26 | 5e-07 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | -0.24 | 7e-07 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | -0.23 | 8e-07 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | 0.22 | 1e-06 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | -0.23 | 1e-06 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.22 | 1e-06 |